Clinical Trial Update: Fecal Calprotectin as a Marker for Macroscopic Recurrence of Crohn's Disease After Intestinal Resection

View source ↗

Summary

This clinical trial update evaluates whether fecal calprotectin can indicate macroscopic recurrence of Crohn's disease after intestinal resection. The study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Complicated Crohn's Disease | Status: UNKNOWN